Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer

被引：0
|
作者：
Marina França de Resende
Samantha Vieira
Ludmilla Thomé Domingos Chinen
Francesco Chiappelli
Francisco Paulo da Fonseca
Gustavo Cardoso Guimarães
Fernando Augusto Soares
Ivan Neves
Simone Pagotty
Peter A Pellionisz
Andre Barkhordarian
Xenia Brant
Rafael Malagoli Rocha
机构：
[1] A. C. Camargo Cancer Hospital,Department of Pathology
[2] UCLA School of Dentistry,Department of Urology
[3] A. C. Camargo Cancer Hospital,undefined
[4] Rua Professor Antônio Prudente 211,undefined
来源：
Journal of Translational Medicine | / 11卷
关键词：
FISH; Immunohistochemistry; Prostate cancer; TOP2A;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] TOP2A and CENPF are synergistic master regulators activated in cervical cancer
    Yu, Beiwei
    Chen, Long
    Zhang, Weina
    Li, Yue
    Zhang, Yibiao
    Gao, Yuan
    Teng, Xianlin
    Zou, Libo
    Wang, Qian
    Jia, Hongtao
    Liu, Xiangtao
    Zheng, Hui
    Hou, Ping
    Yu, Hongyan
    Sun, Ying
    Zhang, Zhiqin
    Zhang, Ping
    Zhang, Liqin
    BMC MEDICAL GENOMICS, 2020, 13 (01)
  • [32] TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer
    Villman, Kenneth
    Sjostrom, Johanna
    Heikkila, Reino
    Hultborn, Ragnar
    Malmstrom, Per
    Bengtsson, Nils-Olof
    Soderberg, Martin
    Saksela, Eero
    Blomqvist, Carl
    ACTA ONCOLOGICA, 2006, 45 (05) : 590 - 596
  • [33] Proliferation and invasion of colon cancer cells are suppressed by knockdown of TOP2A
    Zhang, Rui
    Xu, Jian
    Zhao, Jian
    Bai, Jing H.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (09) : 7256 - 7263
  • [34] Allelic imbalance at the HER2/TOP2A locus in breast cancer
    Huijsmans, Cornelis J. J.
    van den Brule, Adriaan J. C.
    Rigter, Henny
    Poodt, Jeroen
    van der Linden, Johannes C.
    Savelkoul, Paul H. M.
    Hilbink, Mirrian
    Hermans, Mirjam H. A.
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [35] Allelic imbalance at the HER2/TOP2A locus in breast cancer
    Cornelis J. J. Huijsmans
    Adriaan J. C. van den Brule
    Henny Rigter
    Jeroen Poodt
    Johannes C. van der Linden
    Paul H. M. Savelkoul
    Mirrian Hilbink
    Mirjam H. A. Hermans
    Diagnostic Pathology, 10
  • [36] BRCA1 AND TOP2A GENE AMPLIFICATION AND PROTEIN EXPRESSION IN FOUR MOLECULAR SUBTYPES OF BREAST CANCER
    Mitrovic, Olivera
    Micic, Mileva
    Cokic, V.
    Koko, Vesna
    Dikic, Dragoslava
    Budec, Mirela
    Vignjevic, Sanja
    Brekovic, Tijana
    ARCHIVES OF BIOLOGICAL SCIENCES, 2013, 65 (02) : 511 - 518
  • [37] TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer
    Moretti, Erica
    Desmedt, Christine
    Biagioni, Chiara
    Regan, Meredith M.
    Oakman, Catherine
    Larsimont, Denis
    Galardi, Francesca
    Piccart-Gebhart, Martine
    Sotiriou, Christos
    Rimm, David L.
    Di Leo, Angelo
    FUTURE ONCOLOGY, 2013, 9 (10) : 1477 - 1487
  • [38] Low-level TOP2A amplification in prostate cancer is associated with HER2 duplication, androgen resistance, and decreased survival
    Murphy, Amanda J.
    Hughes, Caroline A.
    Barrett, Ciara
    Magee, Hilary
    Loftus, Barbara
    O'Leary, John J.
    Sheils, Orla
    CANCER RESEARCH, 2007, 67 (06) : 2893 - 2898
  • [39] Correlations of TOP2A gene aberrations and expression of topoisomerase IIa protein and TOP2A mRNA expression in primary breast cancer: A retrospective study of 86 cases using fluorescence in situ hybridization and immunohistochemistry
    Meng, Hui
    Chen, Renyin
    Li, Wencai
    Xu, Li
    Xu, Lina
    PATHOLOGY INTERNATIONAL, 2012, 62 (06) : 391 - 399
  • [40] Prognostic Value of TOP2A Gene Amplification and Chromosome 17 Polysomy in Early Breast Cancer
    Zaczek, Anna
    Markiewicz, Aleksandra
    Supernat, Anna
    Bednarz-Knoll, Natalia
    Brandt, Burkhardt
    Seroczynska, Barbara
    Skokowski, Jaroslaw
    Szade, Jolanta
    Czapiewski, Piotr
    Biernat, Wojciech
    Welnicka-Jaskiewicz, Marzena
    Jassem, Jacek
    PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (04) : 885 - 894
12345